FLT3 and acute myeloid leukemia: UDS analysis of FLT3 in the 5 CN-AML from diagnosis to relapse or disease follow-up revealed that all patients actually carried a small ITD+ clone at diagnosis, that was undetectable by conventional Sanger-based analysis (relative abundance of 0,2–2%).